Hints and tips:
Related Special Reports
...One of its aims is to try to tackle the root causes of obesity and diabetes....
...BSP and National Resilience are among a group of highly specialised contract manufacturers benefiting from the boom in obesity drugs....
...“Today’s approval addresses an unmet medical need,” said John Sharretts, director of the diabetes and obesity division in the FDA’s Center for Drug Evaluation and Research in a statement....
...The UK’s National Institute for Health and Care Excellence has recommended Wegovy for people with a BMI of at least 35, or 30-35 if they have other health conditions....
...Ozempic, a diabetes treatment that celebrities take to lose weight, and Wegovy, an anti-obesity medication, have propelled Novo Nordisk to become Europe’s most valuable company and single-handedly stopped...
...University’s National Institute for Stroke and Applied Neuroscience....
...Rosalind RaineSenior Investigator, National Institute for Health and Care Research Professor, Department of Applied Health ResearchUniversity College London, London WC1, UK...
...So far, manufacturing problems have restricted supplies in the UK, but the country’s National Institute for Health and Care Excellence, or NICE, has said the drugs will be paid for by the NHS, but restricted...
...Health and Care Research, Professor, Department of Applied Health Research, University College London, London WC1, UK...
...Huge demand for GLP-1s, the lucrative new class of diabetes and weight-loss drugs that include Wegovy and Zepbound, is testing the capacity of plants capable of producing and administering the drug. 4....
...Walter Koroshetz co-chairs a nationwide research programme at the US National Institutes of Health, designed to uncover the “biologic mechanisms” behind long Covid and potentially develop a cure....
...The restrictions have been less stringent in other European countries, with elderly citizens and people with more common risk factors such as diabetes and obesity able to obtain the drug....
...Researchers have relied on funding from bodies such as the US National Institutes of Health (NIH) and the UK’s National Institute for Health and Care Research. Now, the money is drying up....
...Data from the Stockholm International Peace Research Institute indicates that Russian military expenditure increased year-on-year by 27 per cent in 2022 and 24 per cent in 2023 and is set to rise by another...
...Her work raising the profile of the problem has drawn in more government funding — from Singapore and the US National Institutes on Aging — but it is nowhere near enough....
...diseases such as heart disease and obesity....
...Its health-conscious, well-off members are already at lower risk of obesity, heart disease and other diseases. They may already be motivated to eat better....
...Stubb is a one-time foreign and finance minister who most recently has led a policy research centre at an EU-funded outfit in Italy, the European University Institute....
...But the country has a tradition of finding common ground, says Rune-Christoffer Dragsdahl, secretary-general of the Vegetarian Society of Denmark: “People try to collaborate, even with those they disagree...
...Cancer, stroke and diabetes medications made by Merck, Johnson & Johnson and Bristol Myers Squibb are among the first tranche of medications selected for negotiation....
...Our consortium support has come from bodies such as the National Institute for Health and Care Research (NIHR), the UK government’s major funder of clinical, public health and social care research....
..., heart problems and type 2 diabetes....
...In 2014 a study from Israel’s Weizmann Institute concluded that using artificial sweeteners could promote obesity....
...“The gas is there,” said Gulmira Rzayeva, a senior visiting fellow at the Oxford Institute of Energy Studies, adding that in contrast with Ibadoghlu’s analysis, her research did not show domestic gas demand...
...CRUK has launched a joint research initiative with the US National Cancer Institute to learn more about the causes of early onset cancer. The trend has economic, clinical and social implications....
International Edition